Skip to content

Axalta Coating Systems

US · AXTA #1798 by market cap Listed 1970
32.79 -0.61 -1.83%
Live - 5344 symbols - heartbeat 70s ago · 2026-10-08 08:36
Pre-market 32.30 -1.49%
After-hours 32.79 0.00%
Overnight 32.35 -1.34%
Market cap
7.02B
P/B
2.78
EPS
1.74
Reader sentiment Are you bullish or bearish on AXTA?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
31.11 fair value ≈ 41.88 52.64
  • Implied fair-value range of 31.11-52.64, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -21.7% below the average-multiple fair value of 41.88.

Valuation each multiple against its own 5-year range

P/B ratio 2.83 Cheap vs history 12th percentile
5-year average 3.90 · #38 of 56 in Specialty Chemicals
P/E ratio 20.48 Cheap vs history 33rd percentile
5-year average 24.07 · forward 13.83 · #11 of 32 in Specialty Chemicals
P/S ratio 1.39 In line with history 58th percentile
5-year average 1.35 · forward 1.33 · #27 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Axalta Coating Systems (AXTA) 7.02B 20.12 2.78 0.00%
Linde (LIN) 223.11B 31.22 5.71 1.28%
Ecolab (ECL) 77.96B 37.33 7.75 1.02%
Sherwin-Williams (SHW) 76.47B 29.06 19.84 1.01%
Air Products & Chemicals (APD) 61.93B -1,324.38 4.46 2.59%
PPG Industries (PPG) 23.36B 15.03 2.77 2.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value38.26 Economic moatNarrow UncertaintyHigh

Trading 16.7% below Morningstar's fair value estimate.

Fair value

Axalta Coating Systems Ltd earns a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 15% discount to our quantitative fair value estimate of $38.26 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The firm's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to market value ratio of 1.4, which sits in the top 30% compared with global peers. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. We believe this is a sign that shares could be undervalued.

The firm's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 74.4%, a core component of profitability, falls in the top 45% globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-10-08 08:36:08 · For reference only, not investment advice and not tailored to your situation.